A New Indole Alkaloid From The Traditional Chinese Medicine Chansu
A New Indole Alkaloid From The Traditional Chinese Medicine Chansu
Ying-Hui Dai, An-Dong Wang, Yu-Lin Chen, Ming-Yu Xia, Xin-Yi Shao, Dong-
Chun Liu & Dong Wang
To cite this article: Ying-Hui Dai, An-Dong Wang, Yu-Lin Chen, Ming-Yu Xia, Xin-Yi Shao, Dong-
Chun Liu & Dong Wang (2017): A new indole alkaloid from the traditional Chinese medicine
Chansu, Journal of Asian Natural Products Research, DOI: 10.1080/10286020.2017.1339697
Download by: [The UC San Diego Library] Date: 20 June 2017, At: 02:29
Journal of Asian Natural Products Research, 2017
https://doi.org/10.1080/10286020.2017.1339697
1. Introduction
Chansu is a product of the venom or skin gland secretion of giant toads, including Bufo
bufo gargarizans Cantor and B. melanostictus Schneider [1]. It is an important traditional
Chinese medicine used in China and other Asian countries for a long time in clinic to treat a
number of diseases, such as sore throat, pains, heart failure, cancers [2]. The major chemical
components of Chansu, include bufotoxins, bufogenins, and bufotenines. Bufotoxins, which
exist only in fresh toad secretions, are almost hydrolyzed completely and corresponding
bufogenins are obtained during the drying process [3]. As a kind of lipid-soluble compo-
nents, bufogenins have been generally considered to be the main active substance because
of their significant biological activities such as cardiotonic, hypertensive, and anti-tumor
effects [4,5]. However, the anti-tumor preparations of Chansu or toad skin, such as Chansu
injection and cinobufacini injection, are all water-soluble agents which only contain trace
amounts of bufogenins [6,7]. Therefore, we hypothesize that the water-soluble components
of Chansu also have anti-tumor activity. In order to further investigate the anti-tumor
components, the water-soluble extract of Chansu was isolated to obtain six indole alkaloids.
Among them, 1 was a new compound, and 3 and 4 were isolated for the first time from
Chansu. In addition, the cytotoxic effects against A549 cancer cells of these compounds
were evaluated. Herein, we report the isolation, structural elucidation and bioactivity of
these compounds.
Five known compounds were identified as, N′-methylserotonin (2) [8], 5-hydroxy-1H-in-
dole-3-carbaldehyde (3) [9], N-acetylserotonin (4) [10], 6-hydroxy-1-oxo-3, 4-dihy-
dro-β-carboline (5) [11], and bufoserotonin C (6) [12], by comparing their NMR spectral
data with those reported in the literature.
3. Experimental
3.1. General experimental procedures
UV spectra were recorded on a Shimadzu UV-1700 Spectrophotometer (Shimadzu Co.,
Kyoto, Japan). IR spectra were recorded on a Bruker IFS 55 FTIR spectrometer on KBr
pellets (Bruker Co., Karlsruhe, Germany). NMR spectra were recorded on Bruker ARX-
600 spectrometer (chemical shift values are presented as δ values with TMS as the internal
standard; Bruker Co., Billerica, MA, U.S.A). HR-ESI-MS data were recorded on a Waters
Xevo G2 Q-TOF mass spectrometer (Waters Co., Milford, MA, U.S.A). Semi-preparative
HPLC was performed on a Model LC-10ATVP system consisting of two LC-10AT HPLC
pumps with a SPD-10Avp detector (Shimadzu Co., Kyoto, Japan), and a Phenomenex Luna
C18 column (250 mm × 10.00 mm, 5 μm). Column chromatography (CC) was performed
4 Y.-H. DAI ET AL.
using 101 macroporous resin (0.3–1.25 mm, Cangzhou Bon Adsorber Technology Co.,
Ltd, Cangzhou, China), and Sephadex LH-20 (40–70 μm, Amersham Pharmacia Biotech
AB, Uppsala, Sweden). Human lung adenocarcinoma epithelial cells A549 were purchased
from the American Type Culture Collection (ATCC, Rockville, MD, U.S.A). 5-Flauouracil
(5-FU) is the product of Sigma (the purity was more than 99% detected by HPLC).
3.2. Material
The crude drug Chansu was collected from Linyi, Shandong Province, China, in March
2010 and was authenticated by the Associate Professor Dong Wang from Shenyang
Pharmaceutical University.
3.3.1. N′-Formylserotonin (1)
Yellow amorphous powder from MeOH-H2O (1:9); UV (CH3CN) λmax (log ε): 199 (4.38),
222 (4.36), and 279 (3.74) nm. IR (KBr) vmax (cm−1): 3397, 1630, 1548,1232, and 1191; 1H
NMR (600 MHz, DMSO-d6) and 13C NMR (150 MHz, DMSO-d6) spectral data are shown
in Table 1. Positive ESI-MS: m/z 205.2 [M + H]+, 227.1 [M + Na]+, and negative ESI-MS:
m/z 202.9 [M–H]−; HR-ESI-MS: m/z 205.0981 [M + H]+ (calcd for C11H13N2O2, 205.0977).
Disclosure statement
No potential conflict of interest was reported by the authors.
Funding
This work was financially supported by the National Natural Science Foundation of China [grant
number 81303196]; Natural Science Foundation of Liaoning Province of China [grant number
2015020741]; Scientific Research Foundation for Returned Scholars, Shenyang Pharmaceutical
University [grant number GGJJ2015101].
References
[1] Committee for the Pharmacopoeia of P.R. China, Pharmacopoeia of P.R. China, Vol. I. (China
Medical Science Press, Beijing, 2015), p. 383.
[2] Y. Liang, A.H. Liu, S. Qin, J.H. Sun, M. Yang, P. Li, and D.A. Guo, J. Pharm. Biomed. Anal. 46,
442 (2008).
[3] J. He, Y. Li, N. Si, H.Y. Zhao, B.L. Bian, and H.J. Wang, Acta Pharm. Sin. 49, 1446 (2014).
[4] Y.M. Wang, Z.Y. Li, J.J. Wang, X.Y. Wu, H.M. Gao, and Z.M. Wang, J. Asian Nat. Prod. Res. 17,
364 (2015).
[5] Y. Zhang, Y.K. Qiu, K. Liu, Y.T. Jiang, J.Y. Chen, and D.Q. Dou, Chin. Tradit. Herb. Drugs. 37,
1905 (2006).
[6] L.X. Yang, H.Y. Zhao, S.F. Yuan, Y.J. Li, B.L. Bian, and H.J. Wang, Chin. J. Exp. Tradit. Med.
Formulae. 19, 87 (2013).
[7] H.Y. Zhao, F.K. Wu, Y.K. Qiu, Z. Wu, Y.T. Jiang, and J.Y. Chen, J. Asian Nat. Prod. Res. 12, 793
(2010).
[8] P. Zhang, Z. Cui, Y.S. Liu, and Y. Sheng, J. Shenyang Pharm. Univ. 23, 216 (2006).
[9] P. Sauleau, M.T. Martin, M.E.T.H. Dau, D.T.A. Youssef, and M.-L. Bourguet-Kondracki, J. Nat.
Prod. 69, 1676 (2006).
[10] S.W. Yang and G.A. Cordell, J. Nat. Prod. 60, 230 (1997).
[11] R.H. Liu, H. Luo, Y.L. Li, M. Yang, X.K. Xu, H.L. Li, Y.H. Shen, C. Zhang, J. Su, and W.D. Zhang,
Chem. Nat. Compd. 45, 599 (2009).
[12] R.H. Liu, H. Luo, Y.L. Li, M. Yang, H.L. Li, Y.H. Shen, C. Zhang, J. Su, and W.D. Zhang, Helv.
Chim. Acta. 90, 2427 (2007).
[13] Y. Kamano, H. Morita, R. Takano, A. Kotake, T. Nogawa, H. Hashima, K. Takeya, H. Itokawa,
and G.R. Pettit, Heterocycles 50, 499 (1999).
[14] R.F. Xie, Z.C. Li, B. Gao, Z.N. Shi, and X. Zhou, J. Ethnopharmacol. 141, 692 (2012).
[15] E.K. Davison and J. Sperry, Org. Biomol. Chem. 13, 7911 (2015).
[16] M.Y. Xia, M.W. Wang, Z. Cui, S.I. Tashiro, S. Onodera, M. Minami, and T. Ikejima, J. Asian
Nat. Prod. Res. 8, 335 (2006).